Record quarter for Allergan

Wednesday, November 12 2014 | 00 h 00 min | News

In the third quarter of 2014, Allergan posted its strongest sales increase in the company’s history.

Allergan’s sales were CA$2 billion in the third quarter, up by 17.2% compared with the same period in 2013. Earnings totalled CA$350 million.

Pharmaceutical eyecare products (including Refresh and Restasis) showed a 14.2% sales increase to CA$915 million.

Allergan could not miss out on trumpeting its success, and perhaps it was thumbing its nose at Valeant. The latter is attempting to acquire Allergan and recently boasted its… second best quarter ever (see news clip from October 30).

For more information: http://agn.client.shareholder.com/releasedetail.cfm?ReleaseID=878172

Served with Style

Created with French chef Mathieu Pérou, Silure de Loire pairs a round acetate silhouette with tortoise tones, subtle green accents and resin details inspired by fish scales.

Learn More

Transitions Students of Vision 2026 - EN

Students of Vision Challenges Future Eye Care Professionals to Reimagine Light Management

The Students of Vision Scholarship Program, presented by Transitions Optical and the Opticians Association of Canada, challenges future eye care professionals to develop a creative initiative that helps young adults better understand the impact of light on visual comfort, performance and everyday life. Top submissions will receive scholarships and smart eyewear equipped with Transitions lenses.